German Pediatric Sedation Survey: Frequent Midazolam Use Did Not Measure Adverse-Event Rates

A nationwide center survey described sedation resources and drug choices, but did not directly quantify complications.

Practice and infrastructure

Of 305 pediatric hospital settings contacted, 138 returned questionnaires. Midazolam, ketamine or esketamine, and propofol were the most widely used sedatives. Respondents also reported gaps in selected equipment and staffing standards, varying by procedure.

Reported capacity is a different endpoint

The survey did not collect rates of sedation-related adverse events, so staffing or equipment findings cannot be translated into a midazolam complication rate. Less than half the centers responded, and omitted answers and self-report create uncertainty. The results identify organizational questions for further assessment rather than proving harm in a specific procedure. A case review should establish who administered sedation, who monitored the patient, available rescue resources, and the documented response. Knowing that a drug was commonly used does not establish that a particular administration met local requirements.

Source paper

Original analysis of the supplied journal article, identified as PMC6998146.

Related research

• Infant CT Trial Found Higher Initial Midazolam Success but Frequent Need for Rescue Sedation
• Factor-XIa Inhibitor Study Used Midazolam to Measure CYP3A Interaction Rather Than Sedation Benefit